SCHEMBL5716360

SCHEMBL5716360

CS(=O)(=O)Nc1ccc(CNO)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.66
ALDH1A1 P00352 1/20 0.66
LMNA P02545 1/20 0.66
HPGD P15428 1/20 0.66
HTT P42858 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
TRPV1 Q8NER1 1/20 0.55
EPHX2 P34913 1/20 0.54
NR1H4 Q96RI1 1/20 0.54
KEAP1 Q14145 1/20 0.50
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
ADRB2 P07550 1/20 0.48
ADRB1 P08588 1/20 0.48
ADRB3 P13945 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13538978 0.82 HPGD (0.74) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL1752456 0.81 HPGD (0.66) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL1752455 0.81 HPGD (0.66) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL2206733 0.81 HPGD (0.66) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL13118098 0.80 EPHX2 (0.61) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL5313569 0.80 EPHX2 (0.61) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL5742854 0.80 HPGD (0.70) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL6014610 0.79 HPGD (1.00) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL25176117 0.79 SMN1; SMN2 (0.58) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL12054668 0.78 KEAP1 (0.75) KDM4EALDH1A1LMNAHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558574-A4 NOVEL N-HYDROXY THIOUREA, UREA AND AMIDE COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME DIGITAL BIOTECH CO LTD (KR) 2006-06-21 EP disclosed
US-20050288369-A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same DIGITAL BIOTECH CO., LTD. (KR) 2005-12-29 US disclosed
EP-1558574-A1 NOVEL N-HYDROXY THIOUREA, UREA AND AMIDE COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Digital Biotech Co., Ltd. (KR) 2005-08-03 EP disclosed
WO-2004035533-A1 NOVEL N-HYDROXY THIOUREA, UREA AND AMIDE COMPOUNDS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME DIGITAL BIOTECH CO., LTD. (KR) 2004-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288369-A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same HRH2, HRH4, NMUR2 KDM4E 3793/4885ALDH1A1 1397/4885LMNA 4494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.